Funder
National Research Foundation of Korea
Medical Research Center Program
Reference196 articles.
1. Toxicities of immunotherapy for the practitioner;Weber;J. Clin. Oncol.,2015
2. Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma;Fisher;Cancer J. Sci. Am.,2000
3. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab;Topalian;J. Clin. Oncol.,2014
4. Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear;Dimberu;Yale J. Biol. Med.,2011
5. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;N. Engl. J. Med.,1985
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献